Galapagos | GLPG - Despesas Operacionais

Preço das Ações
24.52
Mudança Diária
0.20 0.81%
Mensal
-0.50%
Anual
6.41%
Q2 Previsão
23.62




Despesas Operacionais Alterar Data
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 8.18B 4.35B 2026-03
Biogen USD 1.96B 69.6M 2026-03
Genmab DKK 798M 235M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 5.62B 4.5B 2026-03
Merck EUR 4.78B 669M 2025-12
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Novartis USD 9.29B 507M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03